Table: Sapporo Clinical Lab - 9-MTH group results

Sapporo Clinical Laboratory

08/02/2021 06:30

Feb 8 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.99               13.35            17.23    
                 (-2.7 pct)          (+3.6 pct)       (-2.5 pct)  
  Operating        748 mln             729 mln          620 mln   
                 (+2.5 pct)          (+28.4 pct)      (-34.3 pct) 
  Recurring        759 mln             762 mln          635 mln   
                 (-0.5 pct)          (+30.0 pct)      (-35.4 pct) 
  Net              483 mln             495 mln          407 mln   
                 (-2.5 pct)          (+30.8 pct)      (-22.9 pct) 
  EPS            141.17 yen          144.78 yen       119.03 yen  
  Ann Div                             10.00 yen        10.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T